← Back to Search

Psychosocial Support for Cardiomyopathy

N/A

Recruiting

Led By Jim Cheung, MD

Research Sponsored by Weill Medical College of Cornell University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

All patients with documented diagnosis of Takotsubo Syndrome greater than 18 years old.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, one year

Awards & highlights

Study Summary

This trial will test if joining a virtual support group helps reduce anxiety symptoms over one year.

Who is the study for?

This trial is for adults over 18 with a confirmed diagnosis of Takotsubo Syndrome, which is a type of heart condition. It's not open to those already in psychotherapy, non-English speakers, prisoners, pregnant women, or anyone unable to consent.Check my eligibility

What is being tested?

The trial is testing if joining a virtual support group can reduce anxiety among people with Takotsubo Syndrome after one year compared to those who don't participate in the group.See study design

What are the potential side effects?

Since this intervention involves psychosocial support rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort during discussions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18 and have been diagnosed with Takotsubo Syndrome.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, one year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, one year

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in anxiety level as measured by the STAI.

Secondary outcome measures

Changes in depression as measured by the PHQ-8.

Changes in quality of life as measured by the KCCQ.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Takotsubo Support GroupExperimental Treatment1 Intervention

Participants diagnosed with Takotsubo Syndrome will be enrolled into the study.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor

1,055 Previous Clinical Trials

1,316,247 Total Patients Enrolled

Jim Cheung, MDPrincipal InvestigatorWeill Medical College of Cornell University

1 Previous Clinical Trials

128 Total Patients Enrolled

Media Library

Takotsubo Support Group Clinical Trial Eligibility Overview. Trial Name: NCT05977049 — N/A

Takotsubo Syndrome Research Study Groups: Takotsubo Support Group

Takotsubo Syndrome Clinical Trial 2023: Takotsubo Support Group Highlights & Side Effects. Trial Name: NCT05977049 — N/A

Takotsubo Support Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05977049 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there available slots for prospective participants in this experiment?

"According to the information listed on clinicaltrials.gov, this particular medical trial is no longer taking applications as it was last updated on July 27th 2023 and initiated recruitment on August 1st of that same year. However, 173 other studies are actively looking for participants currently."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Psychosocial Support for Patients With Takotsubo Syndrome

2023. "Psychosocial Support for Patients With Takotsubo Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05977049.

All > Cardiomyopathy